Kewaunee Scientific (KEQU) Stock Price, News & Analysis

Kewaunee Scientific Corporation (NASDAQ: KEQU) is a manufacturing company focused on the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. According to company disclosures, it traces its roots back to 1906 and serves customers that invest in spaces where scientific discovery and technical work occur. Kewaunee is classified in the Other Industrial Machinery Manufacturing industry within the broader manufacturing sector.

The company’s product portfolio includes steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. These products are used in laboratory and healthcare environments and other technical settings. Kewaunee is also described as a designer and manufacturer of technical furniture products for end-use markets that are commercial, life sciences, pharmaceutical, education, government, and military research.

Kewaunee operates through a domestic segment and an international segment. The domestic segment designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and other related products. The international segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. The company has stated that a majority of its revenue is generated by the domestic business segment.

Kewaunee’s corporate headquarters are located in Statesville, North Carolina. The company reports that it maintains sales offices in the United States, India, Saudi Arabia, and Singapore. It operates three manufacturing facilities in Statesville serving both domestic and international markets, and one manufacturing facility in Bangalore, India serving local, Asian, and African markets. This footprint supports its role in supplying laboratory and technical environments across multiple regions.

In addition to its core operations, Kewaunee has expanded its capabilities through acquisitions. The company completed the acquisition of Nu Aire, Inc. (NuAire), which it describes as a leading manufacturer of biological safety cabinets, CO₂ incubators, ultralow freezers, and other essential laboratory products that complement Kewaunee’s existing portfolio. NuAire was founded in 1971 and has headquarters and manufacturing facilities in Plymouth, Minnesota, with additional manufacturing capabilities in Long Lake, Minnesota. Kewaunee also notes that NuAire’s operations are supported by a warehouse partnership in the Netherlands and OEM partnerships in China.

From a financial reporting perspective, Kewaunee provides regular updates on its performance and uses both GAAP and non-GAAP metrics. The company reports domestic, international, and corporate segments, and discloses measures such as EBITDA, Segment EBITDA, Adjusted EBITDA, adjusted net earnings, and adjusted net earnings per share. These non-GAAP measures are described as supplemental to GAAP results and are intended to help management and investors compare performance over time and across companies, particularly by adjusting for items such as professional and other fees related to the acquisition and integration of NuAire and related tax impacts.

Kewaunee’s business is closely tied to laboratory construction and laboratory infrastructure. Company communications highlight that its domestic and international segments are influenced by project delivery timelines, customer site conditions, and broader construction-related scheduling. The company also discusses its order backlog as an indicator of demand for its products and services across the markets it serves.

Corporate communications emphasize ongoing strategic investments in people, processes, and technology at the corporate level to support anticipated growth, including investments related to compliance requirements such as Sarbanes-Oxley 404(b) readiness. Kewaunee also references a capital allocation strategy that has included share repurchases under a Board-authorized share repurchase program and the use of debt financing and refinancing to support acquisitions and reduce interest expense.

Through its combination of technical furniture manufacturing, laboratory infrastructure design and installation, and specialized laboratory equipment via NuAire, Kewaunee positions itself as a participant in global markets for laboratory, healthcare, and technical environments. Its long operating history, multi-segment structure, and international manufacturing and sales presence are central elements of its corporate profile.